{"disease":{"id":"japanese","name":"japanese"},"drugs":{"marketed":[{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Japanese encephalitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Japanese encephalitis (JE)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Japanese encephalitis (JE) booster","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""}],"pipeline":[{"drug_id":"odalasvir-75-mg","indication_name":"Chronic hepatitis C (Japanese population)","indication_type":"pipeline","phase":"Phase 2","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Odalasvir 75 mg","company_name":"Janssen Research & Development, LLC","drug_phase":"discontinued","molecular_target":"Hepatitis C virus NS5A protein","drug_class":"Direct-acting antiviral (DAA); NS5A inhibitor","quality_score":null,"revenue":null,"mechanism":"Odalasvir inhibits hepatitis C virus NS5A protein to block viral replication and assembly."}],"offLabel":[],"totalMarketed":3,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT06372665","title":"Safety Observation of the Japanese Encephalitis Vaccine Given With a Primary Immunization","phase":"","overall_status":"COMPLETED","enrollment_count":15357,"lead_sponsor_name":"Liaoning Chengda Biotechnology CO., LTD","has_results":false},{"nct_id":"NCT07358910","title":"Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Institut Pasteur du Cambodge","has_results":false},{"nct_id":"NCT04691700","title":"GOREISAN for Heart Failure (GOREISAN-HF) Trial","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1179,"lead_sponsor_name":"Takeshi Morimoto","has_results":false},{"nct_id":"NCT04223037","title":"Purified Inactivated Japanese Encephalitis Vaccine","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":1050,"lead_sponsor_name":"Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT04817917","title":"Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang Province","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":712,"lead_sponsor_name":"Zhejiang Provincial Center for Disease Control and Prevention","has_results":false},{"nct_id":"NCT03282370","title":"Evaluate Safety and Immunogenicity of a Vero Cell-Derived JE Vaccine in 9-24 Months of Age Children in Vietnam","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":655,"lead_sponsor_name":"National Institute of Hygiene and Epidemiology, Vietnam","has_results":false},{"nct_id":"NCT02880865","title":"Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":628,"lead_sponsor_name":"PATH","has_results":true},{"nct_id":"NCT06825312","title":"Immunogenicity, Safety, and Antibody Persistence of Different Immunization Strategies Against Japanese Encephalitis","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":600,"lead_sponsor_name":"Liaoning Chengda Biotechnology CO., LTD","has_results":false},{"nct_id":"NCT00249769","title":"Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"PATH","has_results":true},{"nct_id":"NCT01001988","title":"Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Toddlers","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":596,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT02514746","title":"Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster Dose","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":561,"lead_sponsor_name":"PATH","has_results":true},{"nct_id":"NCT01190228","title":"Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CV","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":454,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT06331702","title":"Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":408,"lead_sponsor_name":"Liaoning Chengda Biotechnology CO., LTD","has_results":false},{"nct_id":"NCT06680128","title":"A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":402,"lead_sponsor_name":"SK Bioscience Co., Ltd.","has_results":false},{"nct_id":"NCT00463476","title":"Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE Vaccine","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":305,"lead_sponsor_name":"PATH","has_results":true},{"nct_id":"NCT00463684","title":"Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of Age","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":278,"lead_sponsor_name":"PATH","has_results":true},{"nct_id":"NCT06678373","title":"Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence Areas","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":250,"lead_sponsor_name":"Liaoning Chengda Biotechnology CO., LTD","has_results":false},{"nct_id":"NCT03204227","title":"Safety of Vero Cell - Derived Inactivated Japanese Encephalitis Vaccine (JECEVAX) in Children From 9-24 Months of Age","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":220,"lead_sponsor_name":"National Institute of Hygiene and Epidemiology, Vietnam","has_results":false},{"nct_id":"NCT01900444","title":"Study of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South Korea","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":119,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT05962008","title":"Effects of Consumption of Phosphatidylserine on the Cognitive Function","phase":"NA","overall_status":"COMPLETED","enrollment_count":114,"lead_sponsor_name":"Orthomedico Inc.","has_results":false},{"nct_id":"NCT03096795","title":"Safety and Tolerability of MEDI3506 in Healthy Participants, in Participants With COPD and Healthy Japanese Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"MedImmune LLC","has_results":false},{"nct_id":"NCT07393126","title":"Effects of the Consumption of Test Product on Urination in Healthy Japanese Adults","phase":"NA","overall_status":"RECRUITING","enrollment_count":76,"lead_sponsor_name":"Indena S.p.A","has_results":false},{"nct_id":"NCT05683327","title":"The Effect of Oral Hyaluronic Acid (UltraHA®) on the Knee Function","phase":"NA","overall_status":"COMPLETED","enrollment_count":66,"lead_sponsor_name":"Orthomedico Inc.","has_results":false},{"nct_id":"NCT03250598","title":"Study to Evaluate the Pharmacokinetics, Safety, and QTc Effect of AG-348 in Healthy Subjects of Japanese Origin and Non-Asian Origin","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Agios Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT02902978","title":"A Single Dose Study of E6130 in Japanese Healthy Adult Male Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"EA Pharma Co., Ltd.","has_results":false},{"nct_id":"NCT02933710","title":"Postmarketing Surveillance Study for IMOJEV® in Republic of Korea","phase":"","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":false},{"nct_id":"NCT04238650","title":"A Pharmacokinetic Study Comparing MB02 And EU Avastin® In Healthy Male Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"mAbxience Research S.L.","has_results":true},{"nct_id":"NCT03168984","title":"A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of UCB0942 in Healthy Japanese and Caucasian Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"UCB Biopharma S.P.R.L.","has_results":false},{"nct_id":"NCT03808493","title":"A Bioequivalence (BE) Study of TAK-438 Orally Disintegrating (OD) Tablet","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT06907537","title":"A Study to Verify the Sleep-improving Effects of the Test Food Consumption","phase":"NA","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Orthomedico Inc.","has_results":false},{"nct_id":"NCT04075409","title":"A Study to Test the Safety, and Tolerability of Padsevonil in Healthy Male Japanese Study Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":39,"lead_sponsor_name":"UCB Biopharma S.P.R.L.","has_results":true},{"nct_id":"NCT05803083","title":"The Effect of Oral Hyaluronic Acid on the Skin","phase":"NA","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Bloomage Biotechnology Corp., Ltd.","has_results":false},{"nct_id":"NCT03237156","title":"Phase 1 TAK-906 Single and Multiple Ascending Dose Study in Japanese Healthy Male Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT06715475","title":"A Verification Study to Evaluate the Safety of Long-term Consumption of the Test Food","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":24,"lead_sponsor_name":"Orthomedico Inc.","has_results":false},{"nct_id":"NCT03605082","title":"A Study to Test the Safety and Tolerability and Pharmacokinetics of Single Doses of UCB0107 in Healthy Japanese Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"UCB Biopharma S.P.R.L.","has_results":false},{"nct_id":"NCT03920111","title":"Flavivirus Cross-priming Potential of IMOJEV","phase":"NA","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"University of Liverpool","has_results":true},{"nct_id":"NCT03042299","title":"A Phase 1, Bio-equivalence Study of TAK-536 Pediatric Formulation","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT02792062","title":"A Food Effect Study of TAK-385 Final Formulation","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT02533375","title":"Study to Investigate Efficacy and Safety of Adalimumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT04176224","title":"Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral Sclerosis","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Tanabe Pharma Corporation","has_results":true},{"nct_id":"NCT04254913","title":"Clinical Pharmacology Study of Oral Edaravone in Amyotrophic Lateral Sclerosis Patients With Gastrostomy","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Tanabe Pharma Corporation","has_results":true}],"total":41},"guidelines":[],"source":"Drug Landscape verified database"}